Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Echinocandins | 15 | 2019 | 139 | 5.81 | Why? |
| Antifungal Agents | 23 | 2019 | 1828 | 4.70 | Why? |
| Drug Resistance, Fungal | 14 | 2018 | 191 | 4.38 | Why? |
| Candidiasis | 9 | 2018 | 334 | 3.07 | Why? |
| Glucosyltransferases | 7 | 2018 | 29 | 2.56 | Why? |
| Candida | 7 | 2018 | 425 | 2.42 | Why? |
| Fungal Proteins | 8 | 2018 | 133 | 2.37 | Why? |
| Candida glabrata | 4 | 2018 | 50 | 1.74 | Why? |
| Candida albicans | 5 | 2018 | 217 | 1.37 | Why? |
| Lipopeptides | 4 | 2017 | 229 | 1.34 | Why? |
| Fungi | 3 | 2017 | 471 | 1.18 | Why? |
| Aspergillosis | 3 | 2019 | 264 | 1.17 | Why? |
| Invasive Fungal Infections | 2 | 2019 | 274 | 1.13 | Why? |
| Genes, Fungal | 2 | 2017 | 21 | 1.06 | Why? |
| Candidiasis, Invasive | 3 | 2018 | 107 | 0.99 | Why? |
| Azoles | 3 | 2018 | 185 | 0.96 | Why? |
| Microbial Sensitivity Tests | 16 | 2019 | 2886 | 0.95 | Why? |
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2020 | 29 | 0.86 | Why? |
| Annexin A1 | 1 | 2019 | 26 | 0.77 | Why? |
| Haptoglobins | 1 | 2019 | 117 | 0.71 | Why? |
| Abdominal Abscess | 1 | 2017 | 41 | 0.69 | Why? |
| Drug Resistance, Multiple, Fungal | 1 | 2017 | 45 | 0.68 | Why? |
| Keratitis | 1 | 2018 | 102 | 0.67 | Why? |
| Tomography | 1 | 2018 | 183 | 0.67 | Why? |
| Candidemia | 2 | 2018 | 353 | 0.66 | Why? |
| Amphotericin B | 1 | 2018 | 256 | 0.66 | Why? |
| Optical Imaging | 1 | 2018 | 197 | 0.65 | Why? |
| Glycosides | 1 | 2017 | 94 | 0.65 | Why? |
| Mutation | 7 | 2021 | 12376 | 0.63 | Why? |
| Aspergillus fumigatus | 2 | 2017 | 239 | 0.61 | Why? |
| Triterpenes | 1 | 2017 | 199 | 0.57 | Why? |
| Microbiological Techniques | 1 | 2017 | 232 | 0.57 | Why? |
| Mycoses | 2 | 2017 | 589 | 0.50 | Why? |
| Pulmonary Aspergillosis | 1 | 2017 | 408 | 0.47 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2019 | 449 | 0.44 | Why? |
| Aspergillus | 3 | 2019 | 347 | 0.44 | Why? |
| Molecular Diagnostic Techniques | 2 | 2017 | 4239 | 0.43 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.42 | Why? |
| New Jersey | 2 | 2021 | 528 | 0.39 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.38 | Why? |
| Peptides, Cyclic | 1 | 2006 | 223 | 0.27 | Why? |
| Mice | 6 | 2021 | 21357 | 0.24 | Why? |
| C-Reactive Protein | 1 | 2019 | 7972 | 0.23 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.23 | Why? |
| Immunologic Techniques | 1 | 2021 | 71 | 0.22 | Why? |
| Cytochrome P-450 Enzyme System | 2 | 2018 | 144 | 0.21 | Why? |
| Amino Acid Substitution | 2 | 2014 | 1706 | 0.21 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.20 | Why? |
| Disease Models, Animal | 4 | 2018 | 10998 | 0.20 | Why? |
| Chitin Synthase | 1 | 2017 | 1 | 0.19 | Why? |
| Microfluidic Analytical Techniques | 1 | 2020 | 254 | 0.18 | Why? |
| Isoenzymes | 1 | 2017 | 127 | 0.17 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.17 | Why? |
| Peptide Synthases | 1 | 2017 | 9 | 0.17 | Why? |
| Drug Tolerance | 1 | 2017 | 100 | 0.17 | Why? |
| Aminoglycosides | 1 | 2017 | 94 | 0.17 | Why? |
| Cell Wall | 1 | 2017 | 62 | 0.17 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.16 | Why? |
| Qatar | 1 | 2018 | 784 | 0.15 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.15 | Why? |
| Hemoptysis | 1 | 2017 | 172 | 0.14 | Why? |
| beta-Glucans | 1 | 2017 | 176 | 0.14 | Why? |
| Point Mutation | 1 | 2017 | 481 | 0.14 | Why? |
| Immunocompromised Host | 2 | 2021 | 5150 | 0.14 | Why? |
| Extracellular Vesicles | 1 | 2021 | 607 | 0.13 | Why? |
| Ascomycota | 1 | 2014 | 71 | 0.13 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.13 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.13 | Why? |
| Tertiary Healthcare | 1 | 2017 | 616 | 0.12 | Why? |
| Triazoles | 1 | 2017 | 440 | 0.12 | Why? |
| Animals | 7 | 2021 | 78931 | 0.12 | Why? |
| Genotype | 2 | 2021 | 4697 | 0.12 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.12 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2019 | 676 | 0.11 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.11 | Why? |
| Humans | 25 | 2021 | 930598 | 0.10 | Why? |
| Immunization, Passive | 3 | 2021 | 10067 | 0.10 | Why? |
| Kinetics | 1 | 2019 | 3238 | 0.10 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2017 | 634 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.09 | Why? |
| Female | 11 | 2021 | 380317 | 0.09 | Why? |
| Membrane Glycoproteins | 1 | 2017 | 2273 | 0.09 | Why? |
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 2426 | 0.09 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.08 | Why? |
| Sequence Analysis, DNA | 3 | 2018 | 2830 | 0.08 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.08 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.08 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.08 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.08 | Why? |
| Aged | 5 | 2021 | 215776 | 0.08 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.08 | Why? |
| Heterozygote | 1 | 2006 | 249 | 0.07 | Why? |
| Homozygote | 1 | 2006 | 230 | 0.07 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.07 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.07 | Why? |
| Apoptosis | 1 | 2014 | 2335 | 0.07 | Why? |
| Methylprednisolone | 1 | 2014 | 2107 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Biological Products | 1 | 2017 | 2331 | 0.06 | Why? |
| Gene Frequency | 1 | 2006 | 1210 | 0.06 | Why? |
| Male | 7 | 2021 | 367725 | 0.06 | Why? |
| MCF-7 Cells | 1 | 2021 | 199 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.05 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Bodily Secretions | 1 | 2021 | 109 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| RAW 264.7 Cells | 1 | 2021 | 316 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.05 | Why? |
| Circulating MicroRNA | 1 | 2021 | 123 | 0.05 | Why? |
| Agar | 1 | 2019 | 15 | 0.05 | Why? |
| Alleles | 1 | 2006 | 1557 | 0.05 | Why? |
| Adult | 5 | 2021 | 244371 | 0.05 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Genes, rRNA | 1 | 2017 | 10 | 0.05 | Why? |
| Disk Diffusion Antimicrobial Tests | 1 | 2017 | 36 | 0.05 | Why? |
| Chitinases | 1 | 2017 | 8 | 0.04 | Why? |
| Calcineurin | 1 | 2017 | 38 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.04 | Why? |
| Ergosterol | 1 | 2017 | 25 | 0.04 | Why? |
| Chitin | 1 | 2017 | 32 | 0.04 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3633 | 0.04 | Why? |
| Culture Media | 1 | 2019 | 366 | 0.04 | Why? |
| Fluconazole | 1 | 2017 | 145 | 0.04 | Why? |
| Feasibility Studies | 1 | 2006 | 3467 | 0.04 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.04 | Why? |
| Multigene Family | 1 | 2017 | 377 | 0.04 | Why? |
| Voriconazole | 1 | 2017 | 206 | 0.04 | Why? |
| Genetic Fitness | 1 | 2017 | 339 | 0.04 | Why? |
| Blood Culture | 1 | 2017 | 308 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.04 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Anti-Inflammatory Agents | 1 | 2014 | 6153 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.03 | Why? |
| Drosophila melanogaster | 1 | 2014 | 85 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2021 | 23402 | 0.03 | Why? |
| Microbial Viability | 1 | 2017 | 406 | 0.03 | Why? |
| Colombia | 1 | 2017 | 1241 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 176 | 0.03 | Why? |
| Cerebral Infarction | 1 | 2014 | 245 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2014 | 1027 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.02 | Why? |
| Species Specificity | 1 | 2014 | 1356 | 0.02 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.02 | Why? |
| Temperature | 1 | 2019 | 2305 | 0.02 | Why? |
| Mutation, Missense | 1 | 2014 | 863 | 0.02 | Why? |
| Treatment Failure | 1 | 2014 | 2106 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.02 | Why? |
| Biosensing Techniques | 1 | 2020 | 2116 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Fatal Outcome | 1 | 2014 | 3438 | 0.02 | Why? |
| Hematologic Neoplasms | 1 | 2017 | 2105 | 0.02 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.02 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.01 | Why? |
| India | 1 | 2018 | 11875 | 0.01 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
Perlin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(139)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_